City
Epaper

Kayakalp Global Emerges as India's Leading Integrative Dermatology Centre for Vitiligo and Psoriasis Treatment

By ANI | Updated: May 27, 2025 17:33 IST

VMPLFaridabad (Haryana) [India], May 27: In a country where chronic skin diseases affect millions, one institution is rewriting ...

Open in App

VMPL

Faridabad (Haryana) [India], May 27: In a country where chronic skin diseases affect millions, one institution is rewriting the rulebook. Kayakalp Global, based in Faridabad, is rapidly emerging as India's foremost destination for integrative dermatology blending Ayurveda, modern medicine, and technology to treat stubborn conditions like vitiligo and psoriasis at their root.

Today, it is widely recognized as a trusted destination for psoriasis and vitiligo treatment in India, offering holistic, science-backed solutions to patients across the country and abroad.

Founded in 1991, Kayakalp Global has grown under the leadership of Dr. Samyak Dhawan, Co-founder and Director of Operations. An MBBS doctor who chose to walk an unconventional path, Dr. Dhawan envisioned a healthcare model that didn't just treat symptoms cosmetically but addressed the root cause of chronic autoimmune skin conditions. His approach has resulted in a large-scale, multi-city operation with over 150 medical professionals, including Ayurvedic experts, MBBS doctors, dermatologists, and patient care advisors.

In a recent milestone event, the organisation, in collaboration with its NGO arm the Indian Vitiligo Association hosted a free mega medical camp, providing subsidized care and consultations to over 500 patients in a single day. "Skin conditions like vitiligo are not just medical issues, they are deeply social and emotional," said Dr. Dhawan. "Our goal is to ensure that quality care reaches even the remotest corners of India."

Kayakalp Global has also made waves digitally, with its YouTube channel crossing 300,000 subscribers making it one of India's largest online communities for skin health advocacy. The platform features detailed patient success stories, expert discussions, and myth-busting content that challenges the stigma surrounding visible skin conditions.

A standout feature of Kayakalp's model is its science-backed Ayurvedic formulations, lab-tested to show clinically verified reductions in inflammation markers such as Substance P and Histamine. "This is the new face of Ayurveda," said Dr. Dhawan. "Rooted in tradition, yet validated by modern science."

The brand's telemedicine infrastructure is another pillar of its outreach, enabling treatment access to patients across tier 2 and tier 3 cities, along with lifetime care programs that continue even after visible recovery.

With a blend of empathy, evidence, and innovation, Kayakalp Global is now positioning itself as a national leader in integrative dermatology pioneering a new era in the treatment of chronic skin conditions with both credibility and compassion.

For more information, visit: www.kayakalpglobal.com

(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL.will not be responsible in any way for the content of the same)

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

Other SportsKKR hosts fan meet-up in Chennai, capturing Knight Riders' spirit in the city

InternationalChina accused of silencing Tibetan voices as activist handed 18-year secret sentence

Politics"EPS unable to name single welfare scheme from his tenure, horrified over losing minority votes": Kanimozhi NVN Somu

CricketIPL 2026: Sara Tendulkar, Saania Chandhok in Stands for LSG vs GT Match in Lucknow

EntertainmentSunny Deol says Asha Bhosle will live through her voice

Business Realted Stories

BusinessFuel supplies remain stable as all refineries operate at high capacity: Govt

Business"No increase in interest rates, 125 bps repo cut benefit passed to customers": PNB CEO

BusinessPakistan inflation hits 74-week high at 12.15 pc: Report

BusinessRs 1.53 lakh crore booster shot fast-tracks growth in Indian Railways

BusinessPMLA tribunal confirms ED's provisional attachments against RCOM and subsidiaries